HOUSTON and VANCOUVER , June 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has appointed... ...http://www.asianhhm.com/pressreleases/essa-pharma-inc-announces-appointment-of-new-director
Asia oncology drugs market research report provides statistics on market revenue, drugs in pipeline, segmentation by generic and patented drugs,... ...http://pressreleaseping.com/market-size-oncology-drug-market-asia-2019
In the aftermath of this year's USTR Special 301 Report, which retained India on the Priority Watch List, industry leaders comment on the Report's... ...http://www.financialexpress.com/article/pharma/management-pharma/2015-ustr-special-301-report-reactions-and-the-way-forward-2/82186/
No major product surprises expected from Sun's pipeline for the next 12 months (Photo: Reuters) Sun Pharmaceutical Industries Ltd's Q4FY15... ...http://www.financialexpress.com/article/markets/indian-markets/sell-rating-on-sun-pharmaceutical-all-round-miss/81539/
Origiin IP Solutions LLP has said that 11 drugs of global pharma majors will be going off patent this year and this would augment generic drug... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=88653&sid=1
For Buying Imatinib & Gleevec Online...